Anaplastic thyroid cancer: Clinical outcomes with conformal radiotherapy

Aarti Bhatia, Archana Rao, Kie Kian Ang, Adam S. Garden, William H. Morrison, David I. Rosenthal, Douglas B. Evans, Gary Clayman, Steven I. Sherman, David Schwartz

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Background. The aim of this study was to review institutional outcomes for anaplastic thyroid cancer treated with conformal 3-dimensional radiotherapy (3DRT) or intensity-modulated radiotherapy (IMRT). Methods. In all, 53 consecutive patients were analyzed. Thirty-one (58%) patients were irradiated with curative intent. Median radiation dose was 55 Gray (Gy; range, 4-70 Gy). Thirteen (25%) patients received IMRT to a median 60 Gy (range, 39.9-69.0 Gy). Thirty-nine (74%) patients received chemotherapy with radiation. Results. The Kaplan-Meier estimate of overall survival (OS) at 1 year for definitively irradiated patients was 29%. Patients without distant metastases receiving ≥50 Gy had superior survival outcomes; 5 such patients had no evidence of disease at last followup. Use of IMRT versus 3DRT did not influence toxicity. Conclusions. Outcomes for anaplastic thyroid cancer treated with 3DRT or IMRT remain equivalent to historical results. Healthy patients with localized disease who tolerate full dose irradiation can potentially enjoy prolonged survival. Biologically targeted radiosensitization merits prioritized investigation.

Original languageEnglish (US)
Pages (from-to)829-836
Number of pages8
JournalHead and Neck
Volume32
Issue number7
DOIs
StatePublished - Jul 1 2010

Fingerprint

Conformal Radiotherapy
Intensity-Modulated Radiotherapy
Radiotherapy
Survival
Radiation
Anaplastic Thyroid Carcinoma
Kaplan-Meier Estimate
Neoplasm Metastasis
Drug Therapy

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology

Cite this

Bhatia, A., Rao, A., Ang, K. K., Garden, A. S., Morrison, W. H., Rosenthal, D. I., ... Schwartz, D. (2010). Anaplastic thyroid cancer: Clinical outcomes with conformal radiotherapy. Head and Neck, 32(7), 829-836. https://doi.org/10.1002/hed.21257

Anaplastic thyroid cancer : Clinical outcomes with conformal radiotherapy. / Bhatia, Aarti; Rao, Archana; Ang, Kie Kian; Garden, Adam S.; Morrison, William H.; Rosenthal, David I.; Evans, Douglas B.; Clayman, Gary; Sherman, Steven I.; Schwartz, David.

In: Head and Neck, Vol. 32, No. 7, 01.07.2010, p. 829-836.

Research output: Contribution to journalArticle

Bhatia, A, Rao, A, Ang, KK, Garden, AS, Morrison, WH, Rosenthal, DI, Evans, DB, Clayman, G, Sherman, SI & Schwartz, D 2010, 'Anaplastic thyroid cancer: Clinical outcomes with conformal radiotherapy', Head and Neck, vol. 32, no. 7, pp. 829-836. https://doi.org/10.1002/hed.21257
Bhatia A, Rao A, Ang KK, Garden AS, Morrison WH, Rosenthal DI et al. Anaplastic thyroid cancer: Clinical outcomes with conformal radiotherapy. Head and Neck. 2010 Jul 1;32(7):829-836. https://doi.org/10.1002/hed.21257
Bhatia, Aarti ; Rao, Archana ; Ang, Kie Kian ; Garden, Adam S. ; Morrison, William H. ; Rosenthal, David I. ; Evans, Douglas B. ; Clayman, Gary ; Sherman, Steven I. ; Schwartz, David. / Anaplastic thyroid cancer : Clinical outcomes with conformal radiotherapy. In: Head and Neck. 2010 ; Vol. 32, No. 7. pp. 829-836.
@article{114a314de0ce43a4b0ae03b6e58ebac9,
title = "Anaplastic thyroid cancer: Clinical outcomes with conformal radiotherapy",
abstract = "Background. The aim of this study was to review institutional outcomes for anaplastic thyroid cancer treated with conformal 3-dimensional radiotherapy (3DRT) or intensity-modulated radiotherapy (IMRT). Methods. In all, 53 consecutive patients were analyzed. Thirty-one (58{\%}) patients were irradiated with curative intent. Median radiation dose was 55 Gray (Gy; range, 4-70 Gy). Thirteen (25{\%}) patients received IMRT to a median 60 Gy (range, 39.9-69.0 Gy). Thirty-nine (74{\%}) patients received chemotherapy with radiation. Results. The Kaplan-Meier estimate of overall survival (OS) at 1 year for definitively irradiated patients was 29{\%}. Patients without distant metastases receiving ≥50 Gy had superior survival outcomes; 5 such patients had no evidence of disease at last followup. Use of IMRT versus 3DRT did not influence toxicity. Conclusions. Outcomes for anaplastic thyroid cancer treated with 3DRT or IMRT remain equivalent to historical results. Healthy patients with localized disease who tolerate full dose irradiation can potentially enjoy prolonged survival. Biologically targeted radiosensitization merits prioritized investigation.",
author = "Aarti Bhatia and Archana Rao and Ang, {Kie Kian} and Garden, {Adam S.} and Morrison, {William H.} and Rosenthal, {David I.} and Evans, {Douglas B.} and Gary Clayman and Sherman, {Steven I.} and David Schwartz",
year = "2010",
month = "7",
day = "1",
doi = "10.1002/hed.21257",
language = "English (US)",
volume = "32",
pages = "829--836",
journal = "Head and Neck",
issn = "1043-3074",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

TY - JOUR

T1 - Anaplastic thyroid cancer

T2 - Clinical outcomes with conformal radiotherapy

AU - Bhatia, Aarti

AU - Rao, Archana

AU - Ang, Kie Kian

AU - Garden, Adam S.

AU - Morrison, William H.

AU - Rosenthal, David I.

AU - Evans, Douglas B.

AU - Clayman, Gary

AU - Sherman, Steven I.

AU - Schwartz, David

PY - 2010/7/1

Y1 - 2010/7/1

N2 - Background. The aim of this study was to review institutional outcomes for anaplastic thyroid cancer treated with conformal 3-dimensional radiotherapy (3DRT) or intensity-modulated radiotherapy (IMRT). Methods. In all, 53 consecutive patients were analyzed. Thirty-one (58%) patients were irradiated with curative intent. Median radiation dose was 55 Gray (Gy; range, 4-70 Gy). Thirteen (25%) patients received IMRT to a median 60 Gy (range, 39.9-69.0 Gy). Thirty-nine (74%) patients received chemotherapy with radiation. Results. The Kaplan-Meier estimate of overall survival (OS) at 1 year for definitively irradiated patients was 29%. Patients without distant metastases receiving ≥50 Gy had superior survival outcomes; 5 such patients had no evidence of disease at last followup. Use of IMRT versus 3DRT did not influence toxicity. Conclusions. Outcomes for anaplastic thyroid cancer treated with 3DRT or IMRT remain equivalent to historical results. Healthy patients with localized disease who tolerate full dose irradiation can potentially enjoy prolonged survival. Biologically targeted radiosensitization merits prioritized investigation.

AB - Background. The aim of this study was to review institutional outcomes for anaplastic thyroid cancer treated with conformal 3-dimensional radiotherapy (3DRT) or intensity-modulated radiotherapy (IMRT). Methods. In all, 53 consecutive patients were analyzed. Thirty-one (58%) patients were irradiated with curative intent. Median radiation dose was 55 Gray (Gy; range, 4-70 Gy). Thirteen (25%) patients received IMRT to a median 60 Gy (range, 39.9-69.0 Gy). Thirty-nine (74%) patients received chemotherapy with radiation. Results. The Kaplan-Meier estimate of overall survival (OS) at 1 year for definitively irradiated patients was 29%. Patients without distant metastases receiving ≥50 Gy had superior survival outcomes; 5 such patients had no evidence of disease at last followup. Use of IMRT versus 3DRT did not influence toxicity. Conclusions. Outcomes for anaplastic thyroid cancer treated with 3DRT or IMRT remain equivalent to historical results. Healthy patients with localized disease who tolerate full dose irradiation can potentially enjoy prolonged survival. Biologically targeted radiosensitization merits prioritized investigation.

UR - http://www.scopus.com/inward/record.url?scp=77954417182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954417182&partnerID=8YFLogxK

U2 - 10.1002/hed.21257

DO - 10.1002/hed.21257

M3 - Article

C2 - 19885924

AN - SCOPUS:77954417182

VL - 32

SP - 829

EP - 836

JO - Head and Neck

JF - Head and Neck

SN - 1043-3074

IS - 7

ER -